Status:
COMPLETED
Oligoantigenic Diet and Core Symptomatology of Children With Attention-Deficit /Hyperactivity Disorder (ADHD).
Lead Sponsor:
Ain Shams University
Conditions:
Attention Deficit Disorder
Eligibility:
All Genders
6-16 years
Phase:
NA
Brief Summary
Fifty patients who diagnosed as ADHD syndrome according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM 5) Criteria aged from 6 to 16 years old will be assigned randomly int...
Eligibility Criteria
Inclusion
- Children fulfilled DSM (5) Criteria for ADHD syndrome aged from 6 to 16 years old on stable pharmacotherapy 8 weeks prior to enrollment with intention to maintain ongoing therapies constant throughout the trial.
Exclusion
- Presence of other medical conditions as chronic medical illness or other neuropsychiatric disorders
- Intelligence quotient (IQ) of patients less than 80%.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06491836
Start Date
September 1 2024
End Date
November 15 2025
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Abbassia, Egypt, 1181